Atlas Trials

Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD

Clinical trial NCT02034630 · UNKNOWN

Trial details

NCT number
NCT02034630
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Genetic Rare Disease
Start date
2014-07-21
Primary completion
2023-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.